Trials / Unknown
UnknownNCT06069817
Impact of High Flow Therapy on Complications Related to Airway Stenting
Impact of High Flow Therapy Through Nasal Cannula on Complications Related to Airway Stenting: a Prospective, Multicentric, Randomized-controlled Trial
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 30 (estimated)
- Sponsor
- Cardarelli Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The application of HFNC therapy in patients with airway stent, improving both humidification and clearance of the airway secretion, could potentially reduce the risk of mucoid impaction, respiratory infections and granulation. HFNC therapy could be superior to nebulization of normal saline (usual care) in order to keep the stent cleaned, reducing, by inference, the risk of complications, as defined above.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | High flow nasal cannula | home treatment with HFNC after airway stent placement both for malignant and benignant central airway obstruction |
| DEVICE | nebulized normal saline | home treatment with nebulized normal saline after airway stent placement both for malignant and benignant central airway obstruction |
Timeline
- Start date
- 2024-01-01
- Primary completion
- 2024-11-01
- Completion
- 2024-12-31
- First posted
- 2023-10-06
- Last updated
- 2024-02-13
Locations
1 site across 1 country: Italy
Source: ClinicalTrials.gov record NCT06069817. Inclusion in this directory is not an endorsement.